Plain English Summary
Background and study aims
Although a depression in the period after giving birth (a postpartum depression) is not a rare condition, many cases go unnoticed. Many women do not recognize the symptoms of postpartum depression (PPD) and fail to seek help and health care professionals who see the mother often do not spot the signs either. When PPD is not identified, this can have a serious impact on the functioning of the mother, the mother-child relationship, the mother's ability to care for their baby and on the family as a whole. One way to better identify PPD in an early stage is by screening women for signs of depression using a questionnaire. There are well developed screening instruments for PPD, including the Edinburg Postnatal Depression Scale (EPDS). In the Netherlands almost all mothers (around 95%) of newborn children visit the Child Health Care Centre (CHC) routinely during the first year after giving birth. Incorporating PPD screening into these visits could therefore provide a unique opportunity to improve the detection and treatment of PPD. The aim of this study is to find out whether screening by CHC with the EPDS is a good way of identifying women with PPD and speeding up the recovery of those with PPD.
Who can participate?
All mothers of children born between the first of December 2012 and the 31st of March 2014, using the offer of Child Health Care in the regions of the participating organizations.
What does the study involve?
Mothers in the screening region are asked to complete the a questionnaire about depression before their planned visit to the CHC center at one, three and six months. The physician discusses the outcome with the mother during the visit. Depending on the score, the mother is referred for further help or treatment or an extra home visit by the CHC nurse. In the control region the mothers and their infants also visit the CHC at one, three and six months, but without completing a depression questionnaire. The physician may ask the mother about depressive symptoms and give advice for further help, but this is not a required part of the consultation. The number of mothers suffering from depression after nine months is then measured.
What are the possible benefits and risks of participating?
There are no direct benefits or risks involved with participating in this study.
Where is the study run from?
Mothers in the screening region attend CHC centres in the region of Twente (GGD Twente), mothers for the control regioon attend CHC centres in the regions of Apeldoorn (Vérian) and Deventer (GGD IJsselland) (Netherlands)
When is the study starting and how long is it expected to run for?
October 2011 to March 2014
Who is funding the study?
Netherlands Organization for Health Research and Development (ZonMw) (Netherlands)
Who is the main contact?
Dr Angarath van der Zee – van den Berg
a.i.vandenberg@utwente.nl
Dr Magda Boere-Boonekamp
m.m.boere-boonekamp@utwente.nl
Trial website
Contact information
Type
Public
Primary contact
Dr Magda Boere - Boonekamp
ORCID ID
http://orcid.org/0000-0001-9707-1056
Contact details
Institute for Innovation and Governance Studies
Dept. Health Technology & Services Research
Ravelijn Building room RA 5254 | PO Box 217
Enschede
7500 AE
Netherlands
Type
Scientific
Additional contact
Mrs Angarath van der Zee - van den Berg
ORCID ID
http://orcid.org/0000-0001-9673-6677
Contact details
Institute for Innovation and Governance Studies
Dep. Health Technology & Services Research
Ravelijn Building room RA 5260 | PO Box 217
Enschede
7500AE
Netherlands
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
AWJT project 15901.0003 (ZonMw)
Study information
Scientific title
The Effectiveness of Screening for Postpartum Depression in Child Health Care: does Screening Improve Maternal Mental Health and the Child’s Socioemotional Development when Compared to Care as Usual?
Acronym
Post-Up study
Study hypothesis
Screening for postpartum depression (PPD) by Child Health Care improves the early detection and results in a more rapid mental recovery of the mothers identified with PPD, better quality of parenting, and less problems in social-emotional development of the children of these mothers.
Ethics approval
The protocol for the study was submitted to the Medical Ethics Committee Twente (MECT) for adjudication. The METC exempted the study from review as the nature of the study was found beyond the remit of the Medical Sciences Research with Human Subjects Act (Wet medisch-wetenschappelijk onderzoek met mensen) and the measures pertaining to confidentiality and informed consent were found appropriate.
Study design
Prospective non-randomised study
Primary study design
Interventional
Secondary study design
Non randomised study
Trial setting
Other
Trial type
Screening
Patient information sheet
Not available in web format, please use contact details to request a participant information sheet in Dutch
Condition
Postpartum depression
Intervention
Participating mothers will be asked to fill in the 10-item EPDS questionnaire prior to their planned visit to the Child Health Care (CHC) center at 1, 3 and 6 months. The CHC physician scores the EPDS during the visit and discusses the outcome with the mother. A score ≥ 13 is interpreted as a high risk to be diagnosed with major depression. If the clinical impression of the WBC physician corresponds to the score, the mother will be advised to consult a family practitioner or mental health professional. In the case of EPDS scores from 9 to 12, the mother is offered a home visit by the CHC nurse. In all cases, the decision on the follow up step after screening is in dialogue with the mother.
In the control region the mothers and their infants visit the CHC at 1, 3 and 6 months. At these visits, the physician has the usual conversation with the mother and can ask about their psychological well-being if they want (this is not a standardized part of the consultation). If post-partum depression is suspected, the mother can be offered a home visit or referred for further help as per standard practice.
Intervention type
Other
Phase
Drug names
Primary outcome measure
Presence of depression (major and minor) at 9 months postpartum, instrument: Dutch translation of the depression subscale of the Mini International Neuropsychiatric Interview at 9 months postpartum.
Secondary outcome measures
Mother:
1. Health-related quality of life is measured using the Short-Form 12-Item Health Survey (SF-12) at 12 months postpartum
2. Maternal anxiety is measured using the 6-item short form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI) at 12 months postpartum
3. Quality of parenting is measured using the Dutch translation of the Maternal Self-Efficacy in the nurturing role questionnaire (SENR) at 12 months postpartum
Child:
Socioemotional development is measured using Ages and Stages Questionnaires: Social Emotional (ASQ:SE), 12 months version, at 12 months postpartum.
Cost-effectiveness:
1. Health care use of the mother is measured using self-report questions at 12 months postpartum
2. Health care use of the infant is measured using self-report questions at 12 months postpartum
3. Proportion of mothers who receive treatment for postpartum depression is measured using self-report questions at 12 months postpartum
4. Sick leave of the mother is measured using self-report questions at 12 months postpartum
Overall trial start date
01/10/2011
Overall trial end date
30/11/2016
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. All mothers of children born between the first of December 2012 and the 31st of March 2014
2. Visiting Child Health Care (CHC) centers in the eastern part of the Netherlands
Participant type
Patient
Age group
Adult
Gender
Female
Target number of participants
To demonstrate the expected effect of the intervantion with a significance level of 5% and a power of 80%, the sample size had to be 1545 women for both groups.
Participant exclusion criteria
1. Insufficient mastery of the Dutch language to fill out questionnaires
2. Not utilizing the offer of Well Baby Care
3. First contact with Well Baby Care after the child was 3 months of age
Recruitment start date
01/12/2012
Recruitment end date
31/03/2014
Locations
Countries of recruitment
Netherlands
Trial participating centre
GGD Regio Twente
Nijverheidstraat 30
Enschede
7511JM
Netherlands
Trial participating centre
Vérian
Postbus 1032
Apeldoorn
7301 BG
Netherlands
Trial participating centre
GGD IJsselland
Schurenstraat 8a
Deventer
7413 RA
Netherlands
Sponsor information
Organisation
University of Twente - Institute for Innovation and Governance Studies
Sponsor details
Drienerlolaan 5
Enschede
7522 NB
Netherlands
+ 31 53 489 3423
info@igs.utwente.nl
Sponsor type
University/education
Website
Funders
Funder type
Not defined
Funder name
Netherlands Organization for Health Research and Development (ZonMw)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Planned submission of at least two publications in a high-impact peer reviewed journal between December 2016 and July 2017.
IPD Sharing plan:
The current data sharing plans for the current study are unknown and will be made available at a later date.
Intention to publish date
31/12/2017
Participant level data
To be made available at a later date
Basic results (scientific)
Publication list